Why Are We Still Cloning Melatonin Receptors? A Commentary

• DOI: 10.1007/978-1-0716-2593-4_29
• Publication Date: 2022-09-30T18:05:01Z
• Authors: Célia Gautier; Isabelle Theret; Giulia Lizzo; Gilles Ferry; Sophie-Pénélope G...; Jean A. Boutin
• Keywords: Receptors, Melatonin; Animals; Exons; Cloning, Molecular; Melatonin

Cloning may seem to be a view from the past. The time before software, computers and AI were invented. It seems to us worth discussing these points in view of our favorite target: the melatoninergic system. In a few stances, it might be important to point out that even in the new era of dry science, there is still a need to experiment and to prove at the bench that our in silico assertions are right. Most of the living animals express to some extend the melatonin receptors. Some of these animal genomes were completely or partially sequenced, and it is tempting to extract from this huge information the sequence(s) of our favorite genes (MLT receptors). Then, why bother cloning, as opposed to simply built the gene and express it in a host cell? Because the genetic boundaries of the expressed sequence(s) are not 100% sure. Because the melatonin receptor gene(s) comprise a first exon 25,000 base pair far from the second one and the limits between this Ex1 and In1-as between In1 and Ex2-are subject to changes that might have a huge impact on the biochemical properties of the receptor, once expressed. Because a receptor is a biochemical entity with characteristics that are important for the functioning of this particular pathway, and more generally, for the functioning of life.